Abstract

The prebiotic inulin has been vaunted for its potential to reduce the risk of colorectal cancer. Inulin fermentation resulting in the production of short-chain fatty acids, primarily butyrate, has been reported to be associated with properties that are beneficial for gut health and has led to an increased consumption of inulin in the Western population through processed food and over-the-counter dietary supplements. However, in clinical trials, there is limited evidence of the efficacy of inulin in preventing colorectal cancer. Moreover, recent data suggest that improper inulin consumption may even be harmful for gastro-intestinal health under certain circumstances. The main objective of this review is to provide insight into the beneficial and potentially detrimental effects of inulin supplementation in the context of colorectal cancer prevention and enhancement of treatment efficacy.

Details

Title
Colorectal cancer and inulin supplementation: the good, the bad, and the unhelpful
Author
Oliero, Manon 1 ; Alaoui, Ahmed Amine 1 ; McCartney, Claire 1 ; Santos, Manuela M 1 

 Nutrition and Microbiome Laboratory, Institut du cancer de Montréal, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) , Montréal, QC, Canada 
Publication year
2024
Publication date
2024
Publisher
Oxford University Press
e-ISSN
20520034
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3168273880
Copyright
© The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.